Data shows non-inferiority of SC administration of Roche’s Perjeta and Herceptin
Roche has published data demonstrating non-inferiority of a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) administered through subcutaneous (SC)...
Expert commentary & analysis from GlobalData
US Senate confirms immuno-oncology-friendly FDA commissioner
China’s Tyvyt beats all top PD-1 inhibitors to the national reimbursement list
Does regular brushing of teeth reduce the risk of heart failure?
Clinicians have a lukewarm response to JAK inhibitor use in PsA
Most Read
Company releases
Emisphere Development Update
Novo Nordisk has announced the Federal Food and Drug Administration (FDA) approved Rybelsus, a semaglutide tablet, to treat adults with...
Tive Solo 5G Tracker
Huber Again Invests in the Future
Peter Huber Kältemaschinenbau AG has marked the official construction commencement for another expansion of its headquarters in Offenburg-Elgersweier with a...
Butterworth’s Statement on Brexit
SCHOTT Glass Ampoules
Ampoules are one of the most common packaging solutions worldwide. SCHOTT's glass ampoules ensure that...
Company whitepapers
IoT Tracking and Monitoring
OnAsset IntelligenceThe Importance of Accurate Temperature Measurement for Vaccine Storage
Lascar ElectronicsHow Virtualisation Can Help Electronic Data Retention
Butterworth LaboratoriesTwo Ways to Minimize the Delamination Risk of Glass Containers
SCHOTT Pharmaceutical SystemsSANOFI Active Ingredient Solutions
Sanofi Active Ingredient SolutionsSerious About Tarmac Time
ECOCOOLKlocke uses NA and ML for Quality Storage
MuntersCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Novartis Stein Cell and Gene Therapy Facility
Novartis opened its new cell and gene therapy facility in Stein, Switzerland, in November 2019. The site is intended to support the production of innovative...
Parsolex’s CGMP Manufacturing Facility Expansion, West Lafayette, Indiana
HALIX cGMP Biopharmaceutical Facility, Leiden
Cobra Biologics Manufacturing Facility Expansion, Matfors
Takeda’s Dengue Vaccine Manufacturing Plant, Singen
Clinical Trials
Data shows non-inferiority of SC administration of Roche’s Perjeta and Herceptin
Roche has published data demonstrating non-inferiority of a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) administered through subcutaneous (SC) injection to standard intravenous (IV)...
Janssen’s Darzalex outperforms standard of care in newly diagnosed multiple myeloma
ViiV submits NDA for drug indicated for multi-drug resistant HIV
ImCheck raises Series B funds to develop gamma delta therapies
Roche secures FDA approval for Tecentriq combination in lung cancer
Design
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
USPTO reverses decision regarding interfering CRISPR patents
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Amneal launches generic to NuvaRing in US
Amneal Pharmaceuticals has launched EluRyng, a generic version of Merck’s birth control medication NuvaRing, following the US Food and Drug Administration (FDA) approval of its...
Novartis and Forendo enter into tissue hormone-focused licensing collaboration
Sanofi and Regeneron to simplify antibody partnership
Flagship Pioneering launches Cellarity for cell behaviour drugs
Janssen’s Darzalex outperforms standard of care in newly diagnosed multiple myeloma
Market Data
WHO announces pilot for insulin prequalification
The World Health Organization (WHO) has launched a pilot programme for insulin prequalification to boost access to diabetes treatment.
Allergan’s Forest to pay $750m to resolve Namenda lawsuit
Amgen to phase out high price version of Repatha
Multiple drug companies settle opioid litigation in Ohio for $260m
Teva recalls Ranitidine medicines batches in UK
Technology
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
Flagship Pioneering launches Cellarity for cell behaviour drugs
Boehringer partners with Healx for AI-based drug discovery
Novartis partners with Amazon for digital boost to manufacturing
Orexo acquires US rights to commercialise vorvida
Your recommended content
Supporting mental health in a business environment
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Identify the key trends in the immuno-oncology market over the next two years
Go Top